FDA Authorizes First COVID-19 Vaccine for Emergency Use — Pfizer-BioNTech

The FDA issues an Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine, the first authorized vaccine in US history for the disease. The authorization follows a 17-4 vote by the Vaccines and Related Biological Products Advisory Committee recommending approval, citing 95% efficacy in clinical trials. The first doses are administered to healthcare workers within days. Moderna's vaccine follows a week later on December 18. Despite Trump's administration funding Operation Warp Speed, he takes no public role in the rollout and continues to undermine confidence in vaccines after the election.